News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–16
Matches
16
Sources here
6
Companies here
1
Search results Stored financial headlines

Active search

16 matching headlines

Ticker or company: SNYRMain company stories
Clear
Latest

TradingView Earnings

SNYR Q2'26 Earnings: EPS estimate is (0.01) USD

Synergy CHC Corp. (SNYR) is scheduled to release its Q2'26 earnings on August 13, with an estimated revenue of $8.00 million and an EPS of ($0.01). The report will provide insight into the company's financial performance compared to previous quarters and analyst expectations.

Main company 🇺🇸 United States
Read at TradingView
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
Investing.com Earnings Main company 🇺🇸 United States

Synergy CHC receives default notice on term loan, $17.6 million outstanding

Synergy CHC Corp. (NASDAQ: SNYR) has received a notice of default on its term loan due to a missed interest payment, leading to the termination of a prior forbearance agreement. The company now owes a forbearance fee and has approximately $17.6 million in principal …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Canada Earnings Main company 🇺🇸 United States

Form 8K Synergy CHC Corp For: 11 August By Investing.com

This article announces the filing of a Form 8K by Synergy CHC Corp on August 11, as reported by Investing.com. It is a brief, factual notification typical of financial news services, indicating a corporate event that necessitates a filing with the SEC. The article …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Earnings Main company 🇺🇸 United States

Synergy CHC Corp (SNYR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Synergy CHC Corp (SNYR), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the company ranks 58 out of 156 in the Pharmaceuticals industry, with two analysts recommending a "Buy" trend. …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Montgomery Advertiser Market update Main company 🇺🇸 United States

New to The Street Launches 1,000+ Commercial TV Blitz for Synergy CHC ($SNYR), Makers of Focus Factor(R) – Adds NewsOut Video PR Coverage & NYC #1 Market Saturation

New to The Street has launched a significant television commercial campaign for Synergy CHC Corp (NASDAQ:SNYR), makers of Focus Factor®, a leading brain health supplement. The campaign includes over 1,000 commercials on national and local networks, NYC market penetration, NewsOut Video PR coverage, distribution …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Synergy CHC: Costco to stop carrying FOCUSfactor after 16 years, 58% of 2025 revenue at risk

Synergy CHC announced that Costco will discontinue carrying its FOCUSfactor products, a partnership that spanned over 16 years. This decision is significant as Costco represented approximately 58% of Synergy CHC's net revenue for the fiscal year ended December 31, 2025. The company expects this …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Balance sheet Main company 🇺🇸 United States

Synergy CHC Corp (SNYR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Synergy CHC Corp (SNYR), indicating a current risk score of 2.64, ranking 121 out of 155 in the Pharmaceuticals industry. The company's beta of 0.00 suggests it tends to underperform during market uptrends but experiences smaller declines …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Synergy CHC Corp (SNYR) Institutional Confidence

This article provides an overview of Synergy CHC Corp's (SNYR) institutional confidence score and shareholder activity as of July 31, 2026. It lists key institutional shareholders and their shareholdings, noting changes for some, such as Ross (Jack) increasing holdings and Sanders Morris LLC decreasing …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Synergy CHC Corp (SNYR) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Synergy CHC Corp (SNYR), indicating a current valuation score of 9.10, which ranks 34 out of 155 in the Pharmaceuticals industry. The P/E ratio is noted as -0.11, significantly below its recent high and above its recent …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Synergy CHC Corp (SNYR) Financial Health: Profitability & Balance Sheet Analysis

The financial health of Synergy CHC Corp (SNYR) is currently rated as weak with a score of 7.16, placing it 122nd out of 155 companies in the Pharmaceuticals industry. The company's latest quarterly revenue saw a year-over-year decrease of 32.77%, and its net profit …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

SNYR|Synergy CHC Corp|Price:0.168|Chg%:-0.003

TradingKey provides a comprehensive stock analysis for Synergy CHC Corp (SNYR), indicating stable fundamentals and high growth potential despite a recent turnaround to loss. The stock is considered fairly valued and has high institutional ownership, with analysts rating it as a "Buy" and expecting …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Synergy CHC Corp (SNYR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Synergy CHC Corp (SNYR), detailing its price momentum score, support and resistance levels, and various technical indicators. It shows that SNYR's current price momentum score is 4.29, ranking 54th in the Pharmaceuticals industry, with the stock trading …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Synergy CHC Corp (SNYR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Synergy CHC Corp (SNYR), categorizing its income by business segments and geographical regions. It shows that Nutraceuticals account for $8.01 million in revenue, while 'Licenses revenue' is $0.00. Geographically, the United States contributes the majority of …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Synergy CHC Corp (SNYR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Synergy CHC Corp (SNYR), listing both major shareholders by proportion and the distribution across different shareholder types like corporations and individual investors. It also provides institutional shareholding data over several quarters, showing changes in the number of …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Synergy CHC Corp (SNYR) Cash Flow

This article provides a detailed cash flow statement for Synergy CHC Corp (SNYR), presenting both annual and quarterly data across various periods. It covers operating, investing, and financing cash flows, along with changes in working capital and other financial metrics. The document also includes …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Sahm Earnings Main company 🇺🇸 United States

Insider Buyers Lose Additional US$75k As Synergy CHC Dips To US$2.7m

Insiders at Synergy CHC Corp. have seen their US$79.6k investment, made at an average price of US$2.85 per share, decrease to US$4.7k due to a recent 14% stock drop. Despite this loss, the article highlights that the CEO and Chairman, Jack Ross, previously bought …

SNYR main company
Sharemaestro market context Price below Trend Line 52 weeks -96.6% · Next-week setup negative 21.3% SNYR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context